Found: 49
Select item for more details and to access through your institution.
Transdifferentiation of mantle cell lymphoma into sarcoma with limited neuromuscular differentiation after conventional chemotherapy.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2022, v. 480, n. 5, p. 1101, doi. 10.1007/s00428-021-03148-9
- By:
- Publication type:
- Article
Evaluation of the dose and efficacy of ruxolitinib in Japanese patients with myelofibrosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Erratum to: Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis.
- Published in:
- 2017
- By:
- Publication type:
- corrected article
Gastric invasion of multiple myeloma presenting as gastrointestinal bleeding.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Cutaneous invasion of leukemia cells during blastic transformation in a post polycythemia vera myelofibrosis patient.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Anaplastic large cell lymphoma with paraneoplastic neutrophilia: an association between IL-17 elevation and aggressive disease progression.
- Published in:
- 2014
- By:
- Publication type:
- Report
JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan.
- Published in:
- International Journal of Hematology, 2014, v. 99, n. 5, p. 625, doi. 10.1007/s12185-014-1567-1
- By:
- Publication type:
- Article
An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP).
- Published in:
- International Journal of Hematology, 2012, v. 95, n. 6, p. 652, doi. 10.1007/s12185-012-1065-2
- By:
- Publication type:
- Article
Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Thrombopoietin (TPO) regulates HIF-1alpha levels through generation of mitochondrial reactive oxygen species.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Activation of FKHRL1 plays an important role in protecting erythroid cells from erythropoietin deprivation-induced apoptosis in a human erythropoietin-dependent leukemia cell line, UT-7/EPO.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Constitutive activation of Stat1 and Stat3 in primary erythroleukemia cells.
- Published in:
- 2002
- By:
- Publication type:
- journal article
A functional role of mitogen-activated protein kinases, erk1 and erk2, in the differentiation of a human leukemia cell line, UT-7/GM: a possible key factor for cell fate determination toward erythroid and megakaryocytic lineages.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Extranodal NK/T-cell lymphoma, nasal type of the uterine cervix: A case report.
- Published in:
- Diagnostic Cytopathology, 2016, v. 44, n. 5, p. 430, doi. 10.1002/dc.23439
- By:
- Publication type:
- Article
Silent Thyroiditis Associated with Ropeginterferon α-2b in a Patient with Polycythemia Vera.
- Published in:
- Internal Medicine, 2024, v. 63, n. 6, p. 843, doi. 10.2169/internalmedicine.2171-23
- By:
- Publication type:
- Article
A Pancreatic Collision Tumor Comprising Mantle Cell Lymphoma and Adenocarcinoma: A Case Report and Literature Review.
- Published in:
- Internal Medicine, 2024, v. 63, n. 4, p. 553, doi. 10.2169/internalmedicine.1937-23
- By:
- Publication type:
- Article
Trisomy 8-positive Polycythemia Vera Complicated with Intestinal Behçet’s-like Disease: A New Perspective for a Clinical Approach.
- Published in:
- Internal Medicine, 2022, v. 61, n. 11, p. 1713, doi. 10.2169/internalmedicine.8395-21
- By:
- Publication type:
- Article
Early Transformation to Classic Hodgkin Lymphoma in a Chemotherapy-naïve Chronic Lymphocytic Leukemia Patient upon Initial Treatment with Ibrutinib.
- Published in:
- Internal Medicine, 2021, v. 60, n. 21, p. 3305, doi. 10.2169/internalmedicine.6979-20
- By:
- Publication type:
- Article
Early Transformation to Classic Hodgkin Lymphoma in a Chemotherapy-naïve Chronic Lymphocytic Leukemia Patient upon Initial Treatment with Ibrutinib.
- Published in:
- Internal Medicine, 2021, v. 60, n. 20, p. 3305, doi. 10.2169/internalmedicine.6979-20
- By:
- Publication type:
- Article
Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinol.
- Published in:
- International Journal of Clinical Oncology, 2016, v. 21, n. 5, p. 996, doi. 10.1007/s10147-016-0971-3
- By:
- Publication type:
- Article
Composite monoclonal B‐cell lymphocytosis and MYD88 L265P‐positive lymphoplasmacytic lymphoma in a patient with IgM light chain amyloidosis: Case report.
- Published in:
- Pathology International, 2020, v. 70, n. 7, p. 458, doi. 10.1111/pin.12937
- By:
- Publication type:
- Article
High prevalence of the MYD88 mutation in testicular lymphoma: Immunohistochemical and genetic analyses.
- Published in:
- Pathology International, 2015, v. 65, n. 10, p. 528, doi. 10.1111/pin.12336
- By:
- Publication type:
- Article
A Very Rare Case of Hypereosinophilic Syndrome Secondary to Natural Killer/T-Cell Lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Correction to: Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 9, p. 3535, doi. 10.1007/s00277-024-05898-3
- By:
- Publication type:
- Article
Expansion of paroxysmal nocturnal hemoglobinuria clones in MPLW515L mutation harboring primary myelofibrosis.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Molecular response of CSF3R T618I harboring chronic neutrophilic leukemia after induction chemotherapy linked to cord blood transplantation.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells.
- Published in:
- Oncogene, 2001, v. 20, n. 57, p. 8249, doi. 10.1038/sj.onc.1205029
- By:
- Publication type:
- Article
Asciminib vs bosutinib in CML patients pretreated with ≥2 tyrosine kinase inhibitors: Results from the Japanese subgroup analysis of ASCEMBL study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 3, p. 2990, doi. 10.1002/cam4.5212
- By:
- Publication type:
- Article
Recurrent CDC25C mutations drive malignant transformation in FPD/AML.
- Published in:
- Nature Communications, 2014, v. 5, n. 8, p. 4770, doi. 10.1038/ncomms5770
- By:
- Publication type:
- Article
Asciminib in Patients With CML-CP Previously Treated With ≥ 2 Tyrosine Kinase Inhibitors: 96-Week Results From the Japanese Subgroup Analysis of the ASCEMBL Study.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 3, p. 305, doi. 10.1007/s12185-024-03805-0
- By:
- Publication type:
- Article
Efficacy and safety outcomes in Japanese patients with low-risk polycythemia vera treated with ropeginterferon alfa-2b.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 2, p. 151, doi. 10.1007/s12185-024-03804-1
- By:
- Publication type:
- Article
Pre-exposure prophylaxis with tixagevimab/cilgavimab for coronavirus disease 2019 (COVID-19) during the Omicron BA.5 wave at a single institution in Japan.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 6, p. 731, doi. 10.1007/s12185-023-03663-2
- By:
- Publication type:
- Article
Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 2, p. 215, doi. 10.1007/s12185-022-03341-9
- By:
- Publication type:
- Article
Clinical characteristics of Japanese patients with polycythemia vera: results of the JSH-MPN-R18 study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Correction to: Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study.
- Published in:
- 2022
- By:
- Publication type:
- corrected article
Presence of bone marrow fibrosis in multiple myeloma may predict extramedullary disease.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 4, p. 544, doi. 10.1007/s12185-022-03373-1
- By:
- Publication type:
- Article
Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 study.
- Published in:
- International Journal of Hematology, 2022, v. 115, n. 2, p. 208, doi. 10.1007/s12185-021-03253-0
- By:
- Publication type:
- Article
JSH Practical Guidelines for Hematological Malignancies, 2018: I. Leukemia-4. Chronic myeloid leukemia (CML)/myeloproliferative neoplasms (MPN).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Myeloid neoplasm with isolated del(5q) and the MPLW515L mutation fulfills the WHO diagnostic criteria for ET.
- Published in:
- International Journal of Hematology, 2020, v. 112, n. 2, p. 238, doi. 10.1007/s12185-020-02872-3
- By:
- Publication type:
- Article
Bortezomib maintenance therapy in transplant-ineligible myeloma patients who plateaued after bortezomib-based induction therapy: a multicenter phase II clinical trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ruxolitinib is effective and safe in Japanese patients with hydroxyurea-resistant or hydroxyurea-intolerant polycythemia vera with splenomegaly.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Case of disseminated molluscum contagiosum caused by ruxolitinib, a Janus kinase 1 and 2 inhibitor.
- Published in:
- Journal of Dermatology, 2016, v. 43, n. 11, p. 1387, doi. 10.1111/1346-8138.13404
- By:
- Publication type:
- Article
Activation of extracellular signal-regulated kinases ERK1 and ERK2 induces Bcl-xL up-regulation via inhibition of caspase activities in erythropoietin signaling.
- Published in:
- Journal of Cellular Physiology, 2003, v. 195, n. 2, p. 290, doi. 10.1002/jcp.10245
- By:
- Publication type:
- Article
Semi-automated histogram analysis of normal bone marrow using <sup>18</sup>F-FDG PET/CT: correlation with clinical indicators.
- Published in:
- BMC Medical Imaging, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12880-022-00757-x
- By:
- Publication type:
- Article
Clinical Efficacy and Safety of First-Line Dasatinib Therapy and the Relevance of Velocity of BCR-ABL1 Transcript Decline for Achievement of Molecular Responses in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Report from the Juntendo Yamanashi Cooperative Study Group
- Published in:
- Oncology, 2018, v. 94, n. 2, p. 85, doi. 10.1159/000481945
- By:
- Publication type:
- Article
Regulation of Both Erythroid and Megakaryocytic Differentiation of a Human Leukemia Cell Line, UT-7.
- Published in:
- Acta Haematologica, 1998, v. 99, n. 3, p. 180, doi. 10.1159/000040834
- By:
- Publication type:
- Article
Active FKHRL1 overcomes imatinib resistance in chronic myelogenous leukemia-derived cell lines via the production of tumor necrosis factor-related apoptosis-inducing ligand.
- Published in:
- Cancer Science, 2007, v. 98, n. 12, p. 1949, doi. 10.1111/j.1349-7006.2007.00623.x
- By:
- Publication type:
- Article